| The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment (NCT02650102) | Shanxi Medical University | 2013-01-01 |
| Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) (NCT01822418) | Central Institute of Mental Health, Mannheim | 2013-01-01 |
| Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia (NCT01683058) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-01-01 |
| Fingolimod in Schizophrenia Patients (NCT01779700) | Indiana University | 2013-01-01 |
| Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (NCT02051387) | Central Institute of Mental Health, Mannheim | 2013-01-01 |
| Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia (NCT01852331) | The University of Hong Kong | 2013-01-01 |
| Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels (NCT01754532) | Shalvata Mental Health Center | 2013-01-01 |
| A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia (NCT01670071) | Johnson & Johnson Taiwan Ltd | 2013-01-01 |
| Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum (NCT01805128) | Centre Hospitalier Universitaire de Nice | 2013-01-01 |
| The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics (NCT03663465) | Calo Psychiatric Center | 2013-01-01 |
| Contrasting Group Therapy Methods for Psychosis (NCT01764568) | University of British Columbia | 2013-01-01 |
| A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) (NCT01617187) | Organon and Co | 2012-12-04 |
| Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study (NCT01689389) | AstraZeneca | 2012-12-01 |
| The Management of Schizophrenia in Clinical Practice (MOSAIC) (NCT01746134) | Genentech, Inc. | 2012-12-01 |
| My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness (NCT01749124) | RAND | 2012-12-01 |
| A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers (NCT01749098) | Biogen | 2012-12-01 |
| Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) (NCT01617200) | Forest Laboratories | 2012-12-01 |
| Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents (NCT01731119) | University of North Carolina, Chapel Hill | 2012-12-01 |
| Antipsychotic Discontinuation in High-risk Subjects (NCT01758887) | Seoul National University Hospital | 2012-12-01 |
| CHANGE -it is About Life (NCT01585493) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2012-12-01 |
| Lifestyle Intervention for Diabetes and Weight Management in Psychosis (NCT01828931) | Centre for Addiction and Mental Health | 2012-12-01 |
| Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia (NCT01795183) | Sanofi | 2012-11-01 |
| A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy Volunteers (NCT01788436) | Janssen Research & Development, LLC | 2012-11-01 |
| Motivation and Executive Control in Schizophrenia (NCT02734927) | Hôpital le Vinatier | 2012-11-01 |
| Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia (NCT01738698) | Shire | 2012-11-01 |
| A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics (NCT01685931) | Xian-Janssen Pharmaceutical Ltd. | 2012-11-01 |
| tDCS to Enhance Cognitive Training in Schizophrenia (NCT01733602) | The University of New South Wales | 2012-11-01 |
| Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (NCT01712646) | National Institute of Mental Health (NIMH) | 2012-10-05 |
| Cross-Sectional Iloperidone IVGTT (NCT01686815) | Massachusetts General Hospital | 2012-10-01 |
| Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant (NCT01774435) | Endo USA Inc., a Keenova Therapeutics Company | 2012-10-01 |
| Kuvan in People With Schizophrenia and Schizoaffective Disorder (NCT01706965) | New York State Psychiatric Institute | 2012-10-01 |
| Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy (NCT01716975) | FORUM Pharmaceuticals Inc | 2012-10-01 |
| Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy (NCT01714661) | FORUM Pharmaceuticals Inc | 2012-10-01 |
| Validating Three Common Occupational Therapy Assessments in Participants With Schizophrenia (NCT02930083) | Taipei City Hospital | 2012-10-01 |
| An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia (NCT01716858) | Chiba University | 2012-10-01 |
| Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia (NCT01663532) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2012-10-01 |
| Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients (NCT01663077) | Tirat Carmel Mental Health Center | 2012-10-01 |
| Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results (NCT04548622) | Yale University | 2012-09-01 |
| Antipsychotic Augmentation With L-Dopa (NCT01636037) | Centre for Addiction and Mental Health | 2012-09-01 |
| The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine (NCT01654640) | Seoul National University Hospital | 2012-09-01 |
| Long-Term Study of MP-214 in Patients With Schizophrenia (NCT01626872) | Tanabe Pharma Corporation | 2012-09-01 |
| A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients (NCT01730768) | Novartis Pharmaceuticals | 2012-09-01 |
| An Open-Label Trial of Tocilizumab in Schizophrenia (NCT01696929) | Brian Miller | 2012-09-01 |
| Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder (NCT01658150) | Icahn School of Medicine at Mount Sinai | 2012-09-01 |
| Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia (NCT01623726) | University of Sao Paulo | 2012-08-01 |
| A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia (NCT01678755) | AbbVie (prior sponsor, Abbott) | 2012-08-01 |
| The Effectiveness of the Meta-cognitive Training Among Patients With Chronic Schizophrenia (NCT02187692) | Medical University of Warsaw | 2012-08-01 |
| Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (NCT01614912) | Sumitomo Pharma Co., Ltd. | 2012-08-01 |
| A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (NCT01614899) | Sumitomo Pharma Co., Ltd. | 2012-07-02 |
| Effects of Eszopiclone on Sleep and Memory in Schizophrenia (NCT01641900) | Massachusetts General Hospital | 2012-07-01 |
| A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia (NCT01592110) | Zogenix, Inc. | 2012-07-01 |
| Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder (NCT01629355) | University Hospital of North Norway | 2012-07-01 |
| Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers (NCT02868307) | Assistance Publique Hopitaux De Marseille | 2012-07-01 |
| A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug (NCT01592201) | Janssen Korea, Ltd., Korea | 2012-07-01 |
| Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia (NCT01903915) | Asan Medical Center | 2012-07-01 |
| Biomarkers in First Episode Schizophrenia (NCT02033382) | NYU Langone Health | 2012-07-01 |
| Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia (NCT01544608) | AstraZeneca | 2012-07-01 |
| A Study of rTMS for Cognitive Deficits in Chronic Patients With Schizophrenia (NCT03273439) | Suzhou Psychiatric Hospital | 2012-07-01 |
| Research Sense of Familiarity in Psychotic Patients (NCT07608250) | University Hospital, Lille | 2012-07-01 |
| A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia (NCT01527305) | Janssen Research & Development, LLC | 2012-06-22 |
| A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg (NCT01654601) | Dong Wha Pharmaceutical Co. Ltd. | 2012-06-01 |
| Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia (NCT01614093) | University of Maryland, Baltimore | 2012-06-01 |
| Apathy in Schizophrenia (NCT01689181) | Institut National de la Santé Et de la Recherche Médicale, France | 2012-06-01 |
| Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia (NCT01623713) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2012-06-01 |
| A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) (NCT01626456) | Alkermes, Inc. | 2012-06-01 |
| Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia (NCT01620086) | University of Arkansas | 2012-06-01 |
| A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia (NCT02192723) | Beijing HuiLongGuan Hospital | 2012-06-01 |
| Anti-Inflammatory Treatment of Schizophrenia (NCT01514682) | University of Maryland, Baltimore | 2012-06-01 |
| Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry (NCT01611337) | Centre Hospitalier Esquirol | 2012-06-01 |
| Brain Imaging, Cognitive Enhancement and Early Schizophrenia (NCT01561859) | Beth Israel Deaconess Medical Center | 2012-06-01 |
| PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) (NCT01542229) | VA Office of Research and Development | 2012-05-03 |
| Social Cognitive Training for Psychosis: Treatment Development (NCT01579422) | Yale University | 2012-05-01 |
| 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (NCT01568216) | Amgen | 2012-05-01 |
| Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia (NCT01773239) | Posit Science Corporation | 2012-05-01 |
| 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) (NCT01568229) | Amgen | 2012-05-01 |
| A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia (NCT01626859) | Tanabe Pharma Corporation | 2012-05-01 |
| Efficacy Study of GAÏA Program Cognitive Remediation of Facial Affects Processing in Schizophrenia (NCT02110771) | Hôpital le Vinatier | 2012-05-01 |
| An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia (NCT01646827) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2012-05-01 |
| A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia (NCT01625897) | Tanabe Pharma Corporation | 2012-05-01 |
| Alleviating the Metabolic Side Effects of Antipsychotic Medications (NCT01567124) | Baker Heart and Diabetes Institute | 2012-05-01 |
| A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia (NCT01529515) | Janssen Research & Development, LLC | 2012-05-01 |
| A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia (NCT01626885) | Tanabe Pharma Corporation | 2012-05-01 |
| Melatonin for Prevention of Metabolic Side Effects of Olanzapine (NCT01593774) | Guilan University of Medical Sciences | 2012-05-01 |
| Safety and Efficacy of MP-214 in Patients With Schizophrenia (NCT01625000) | Tanabe Pharma Corporation | 2012-05-01 |
| Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM) (NCT01655368) | Wolfgang Gaebel, Professor | 2012-05-01 |
| Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems (NCT02366117) | Universidade Nova de Lisboa | 2012-04-01 |
| A Twelve Week, Open Label Extension Study in Patients With Schizophrenia (NCT01566162) | Sumitomo Pharma America, Inc. | 2012-04-01 |
| Antipsychotics and Risk of Hyperglycemic Emergencies (NCT02582736) | Canadian Network for Observational Drug Effect Studies, CNODES | 2012-04-01 |
| Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults (NCT01422902) | Posit Science Corporation | 2012-04-01 |
| EMR Data to Assess Monitoring of Patients Treated With Quetiapine (NCT01793324) | AstraZeneca | 2012-04-01 |
| Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic (NCT02128919) | Nathan Kline Institute for Psychiatric Research | 2012-04-01 |
| Behavior During Experimentally Induced Pain (NCT01594528) | Centre Hospitalier Esquirol | 2012-04-01 |
| Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia (NCT01563016) | The University of Hong Kong | 2012-04-01 |
| Once-Daily Asenapine for Schizophrenia (NCT01549041) | Duke University | 2012-04-01 |
| Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients (NCT01547026) | University of Konstanz | 2012-04-01 |
| Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia (NCT01929889) | Northwestern University | 2012-04-01 |
| The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia. (NCT01897064) | New York State Psychiatric Institute | 2012-04-01 |
| Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia (NCT01545999) | Centre for Addiction and Mental Health | 2012-03-01 |
| Past Pain Experience and Perception of Experimental Pain (NCT01575912) | Centre Hospitalier Esquirol | 2012-03-01 |
| Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations (NCT01512290) | UMC Utrecht | 2012-03-01 |